Detected ·

Beacon Biosignals

——

Beacon Biosignals announced an extension of its Series B to $97.2 million, bringing total funding above $132 million. New investors JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next joined the round.

Website
beacon.bio
Amount
—
Stage
—
Event
Funding round
Detected
2026-04-07 12:03:50 UTC
Signal ID
6316eebe-7db9-4190-b6fe-c1fc3821b833

As the API returns it

{
  "id": "6316eebe-7db9-4190-b6fe-c1fc3821b833",
  "created_at": "2026-04-07T12:03:50.761651Z",
  "company_name": "Beacon Biosignals",
  "company_website_url": "beacon.bio",
  "company_linkedin_url": "https://www.linkedin.com/company/beaconbiosignals",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Beacon Biosignals announced an extension of its Series B to $97.2 million, bringing total funding above $132 million. New investors JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next joined the round.*"
}

Latest rounds